Elonva 150Mcg Solution For Injection is used to support pregnancy and conception through assisted reproductive technologies, and to treat hypogonadotropic hypogonadism in adolescent males.

Elonva Composition

Each Elonva injection contains 150 mcg of corifollitropin alfa, which acts similarly to follicle-stimulating hormone (FSH), one of the key reproductive hormones.

Elonva injection uses

Elonva injections are used for:

• Controlled ovarian stimulation in combination with GnRH antagonists, to promote the growth of multiple ovarian follicles and support the success of assisted reproduction techniques (such as IVF).

• Treatment of hypogonadotropic hypogonadism in adolescent males aged 14 years and older, in combination with human chorionic gonadotropin (HCG).

Elonva Dosage

The doctor determines the appropriate dose of Elonva.

• The recommended dose is 100 mcg for women who weigh 60 kg or less and are 36 years old or younger.

• The recommended dose is 150 mcg for women who weigh more than 60 kg, regardless of age, or for women who weigh 50 kg or more and are older than 36 years.

• For males, Elonva is administered once every two weeks in the morning.

• The injections are given subcutaneously (under the skin).

Elonva 150 mcg Side Effects

Elonva injections may cause some side effects, including:

• Headache

• Nausea

• Pelvic pain

• Breast pain

• Fatigue

Contraindications

Elonva should not be used in cases of:

• Hypersensitivity to any of its components

• Tumors of the ovary, breast, uterus, pituitary gland, or hypothalamus

• Unexplained vaginal bleeding

• Primary ovarian failure

• Ovarian cysts or enlargement

• Uterine fibroids that may prevent pregnancy

• Congenital abnormalities of the reproductive system

• Risk of ovarian hyperstimulation syndrome (OHSS)

Storage and Handling

• Keep out of reach of children.

• Store in a refrigerator at 2–8°C.

• Do not freeze.

• May be stored at 25°C or below for up to one month.

• Keep in the original package, protected from light.